DN
Therapeutic Areas
ExploRNA Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Tumor-specific antigen vaccine | Oncology | Pre-clinical |
| Cytokine expression for T-cell promotion | Oncology | Pre-clinical |
Leadership Team at ExploRNA Therapeutics
JJ
Jacek Jemielity
Chief Executive Officer
JK
Joanna Kowalska
Chief Technology Officer
JG
Jakub Gołąb
Chief Scientific Officer
MG
Mateusz Gołąb
Chief Financial Officer, Board Member
TP
Tomasz Piec
Board Member
MB
Marek Baranowski
Director of Research and Quality Development
PS
Piotr Stępniak
Director of Business Development